MedTrace Logo

Role of 3D Tomography in Breast Cancer

NCT01090687 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2013-08-01

No results posted yet for this study

Summary

The primary aim of this pilot study is to define the role of dedicated cone beam breast computed tomography in breast cancer imaging. This research is a prelude of a more comprehensive clinical trial that may follow.

Conditions

Interventions

RADIATION

computed tomography (CT scan)

Subjects will undergo cone beam breast CT scan

DEVICE

computed tomography (CT scan)

Subjects will undergo cone beam breast CT scan

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Rochester

    lead OTHER

Principal Investigators

  • Andrew Karellas, PhD · University of Massachusetts, Worcester

  • Stephen Glick, PhD · University of Massachusetts, Worcester

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01090687 on ClinicalTrials.gov